These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 30873179)

  • 21. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
    Nagarsheth N; Wicha MS; Zou W
    Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine-chemokine receptors in cancer immunotherapy.
    Stewart TJ; Smyth MJ
    Immunotherapy; 2009 Jan; 1(1):109-27. PubMed ID: 20635978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines and chemokine receptors: A new strategy for breast cancer therapy.
    Liu H; Yang Z; Lu W; Chen Z; Chen L; Han S; Wu X; Cai T; Cai Y
    Cancer Med; 2020 Jun; 9(11):3786-3799. PubMed ID: 32253815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL7 Signaling in the Tumor Microenvironment.
    Lee YS; Cho YB
    Adv Exp Med Biol; 2020; 1231():33-43. PubMed ID: 32060844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.
    Arora S; Khan S; Zaki A; Tabassum G; Mohsin M; Bhutto HN; Ahmad T; Fatma T; Syed MA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):720-736. PubMed ID: 35257861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis.
    Valdivia-Silva J; Chinney-Herrera A
    Int Rev Cell Mol Biol; 2024; 388():124-161. PubMed ID: 39260935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines and the immune response to cancer.
    Ozga AJ; Chow MT; Luster AD
    Immunity; 2021 May; 54(5):859-874. PubMed ID: 33838745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges.
    Duan J; Wang Y; Jiao S
    Cancer Med; 2018 Sep; 7(9):4517-4529. PubMed ID: 30088347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets.
    Li Z; Yu S; Jiang Y; Fu Y
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5089-5095. PubMed ID: 35732904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
    Opdenakker G; Van Damme J
    Int J Dev Biol; 2004; 48(5-6):519-27. PubMed ID: 15349826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The good and the bad of chemokines/chemokine receptors in melanoma.
    Richmond A; Yang J; Su Y
    Pigment Cell Melanoma Res; 2009 Apr; 22(2):175-86. PubMed ID: 19222802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of chemokines in small cell lung cancer: Road signs for metastasis, heterogeneity, and immune response.
    Khan P; Fatima M; Khan MA; Batra SK; Nasser MW
    Semin Cancer Biol; 2022 Dec; 87():117-126. PubMed ID: 36371025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.
    Sjöberg E; Meyrath M; Chevigné A; Östman A; Augsten M; Szpakowska M
    Adv Cancer Res; 2020; 145():99-138. PubMed ID: 32089166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokines: agents for the immunotherapy of cancer?
    Homey B; Müller A; Zlotnik A
    Nat Rev Immunol; 2002 Mar; 2(3):175-84. PubMed ID: 11913068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functional roles of chemokines and chemokine receptors in colorectal cancer progression.
    Yue M; Chen MM; Zhang B; Wang Y; Li P; Zhao Y
    Biomed Pharmacother; 2024 Jan; 170():116040. PubMed ID: 38113624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
    Mooradian MJ; Sullivan RJ
    Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines, chemokine receptors, and cancer metastasis.
    Kakinuma T; Hwang ST
    J Leukoc Biol; 2006 Apr; 79(4):639-51. PubMed ID: 16478915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokines: can effector cells be redirected to the site of the tumor?
    Dubinett SM; Lee JM; Sharma S; Mulé JJ
    Cancer J; 2010; 16(4):325-35. PubMed ID: 20693843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.
    Jin J; Zhao Q
    Theranostics; 2020; 10(14):6231-6244. PubMed ID: 32483450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.